Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Sunpeaks Ventures, Inc. (OTCBB: SNPK) Featured By Small Cap Investment Research

(EMAILWIRE.COM, April 11, 2012 ) Los Angeles, CA -- Small Cap Investment Research (SmallCapInvestmentResearch.com), a developer, publisher and marketer of independent research products, announced today the release of an updated research report on Sunpeaks Ventures, Inc (OTCBB: SNPK) (“the Company”). Small Cap Investment Research has issued a “STRONG BUY” and a target price of $9.00 on shares of this company.



The report examines the potential continued growth of the Company as it continues to gain market share, and examines the outlook for short and long-term investors. “We were pleased to have the opportunity to report on this company and the industry factors that affect it. The report presents a great overview of the Company and its potential for the long-term with a constantly improving industry dynamic.” – Small Cap Investment Research.



Recently, Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS") announced that HDS has signed a Letter of Intent with PharmaLife® for placement of Clotamin® with leading pharmacies in the Russian Federation.



The Letter of Intent outlines the terms and conditions of a proposed transaction that could see Clotamin distributed by several pharmacy and retail chains in the Russian Federation, including product placement with leading wholesalers Imperia-Pharma, the Dr. Stoletov pharmacy chain (414 locations), and other small retail pharmacies associated with Imperia-Pharma. PharmaLife is also expected to secure timely product registration within the Russian Federation for Clotamin distribution and conduct local market research to support a successful product launch.

The entire report can be found on http://www.smallcapinvestmentresearch.com/featured-companies/ .



About Small Cap Investment Research:

Small Cap Investment Research specializes in providing readers with an in-depth analysis of undervalued companies. The company’s role as an independent research analyst firm is to “separate the wheat from the chaff” and help investors receive unbiased, thought-provoking, and quality investment research. SCIR’s philosophy in research is to encapsulate realistic investment ratings, target prices, and forward-looking financial models. The reports contain hard-hitting, meticulously researched facts on companies, their fundamentals, and their industries, validating a company’s prospects and enabling the reader to objectively evaluate the company’s value. The media and savvy investors alike view this model as how investment research needs to be performed devoid of any partiality.



About Sunpeaks Ventures, Inc.:

Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market. HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.



Forward-Looking Statements

Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to risks and uncertainties. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import also identify forward-looking statements. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of Sunpeaks Ventures, Inc. (OTCBB: SNPK) can be found in the filings of Sunpeaks Ventures, Inc. with the U.S. Securities and Exchange Commission.



Release of Liability: Through use of this website viewing or using you agree to hold SCIR, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. We have been compensated six thousand dollars for this SNPK report. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. SCIR encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SCIR makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies.



Indepedent Research Investment
Derrick Brazinski
3104567798
dbrazinski@indedentresearchinvestment.com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.

Prosecutors seek congressional probe of supplement industry
1 Apr 2015 at 11:05pm
ALBANY, N.Y. (AP) ? A group of 14 attorneys general has asked Congress to launch an investigation of the herbal supplements industry and to consider giving the U.S. Food and Drug Administration stronger oversight of the industry, New York Attorney General Eric Schneiderman announced.


Texas bill would bar gun ownership status in medical record
1 Apr 2015 at 10:45pm

DALLAS (AP) ? Texas lawmakers are considering a bill that would keep a person's gun ownership status from being listed in their medical records, a move health providers worry would be an unnecessary government intrusion that harms their consultations with patients.



Packed with health benefits, coffee gains ground with experts
1 Apr 2015 at 8:57pm

Long viewed as a controversial dark substance, coffee is gaining ground among medical experts who say it can protect against heart disease, Parkinson's, Alzheimer's and diabetes, even if it is decaffeinated. Multiple studies published worldwide in recent years have concluded that coffee can be good for the health. "We looked at all the science," said Miriam Nelson, a professor in the School of Nutrition Science and Policy at Tufts University, and a member of the committee that wrote the guidelines. "We have found no negative, adverse effects on health when you drink up to three to five cups a day," she told AFP.



Questions persist about sexual effects of baldness drug
1 Apr 2015 at 5:29pm

A review of 34 clinical trials on a popular drug to treat hair loss in men found that none of the studies adequately reported on sexual side effects, researchers said. The findings raise serious questions about whether the drug -- known as finasteride and marketed as Propecia and Proscar, among other names -- is safe, said the report by scientists at Northwestern University, published in the Journal of the American Medical Association (JAMA) Dermatology on Wednesday. The drug, approved in 1992, works by interfering with testosterone, and the pharmaceutical giant Merck lists decreased sex drive, impotence and problems with ejaculation among its common side effects.



Children's Health for Corporate Profits- A Fair Compromise?
1 Apr 2015 at 4:55pm

A "chemical safety" bill is rapidly moving through the U.S. Senate. Writing in Bloomberg, Paul Barrett decries the "hyperbole" of those of us who are calling for stronger health and environmental protections than the industry-backed bill delivers. Barrett notes that many agree that our current chemical law is broken, but who could have believed...



Last Cuban Ebola medics leave S.Leone, new clampdown for Easter
1 Apr 2015 at 4:35pm

The last remaining Cuban medics sent to Sierra Leone in October last year to help in the fight against Ebola left the country on Wednesday, as the number of infections there is falling. The 66 remaining Cuban medics who answered a call from the World Health Organization to come to Sierra Leone as Ebola raged six months ago left on Wednesday, saying they believed the country was well on the way to defeating the virus. The head of the Cuban delegation, Doctor Jorge Delgado Butillo, told AFP by telephone his staff had "helped to save the life of a great number of people infected with Ebola". Sierra Leone's National Ebola Response Centre (NERC) said during the three-day nationwide clampdown, 263 sick people were evacuated from their homes of which 10 were confirmed to have tested positive for the virus.



Ebola vaccine tests show it could 'neutralise' virus: Geneva hospital
1 Apr 2015 at 2:57pm

An experimental Ebola vaccine tested on humans in Europe and Africa sparks the production of the antibodies needed to neutralise the deadly virus, a Geneva hospital said Wednesday. There is no licensed treatment or vaccine for Ebola, and the World Health Organization last year endorsed rushing potential ones through trials in a bid to stem the epidemic still simmering in west Africa. Initial clinical trials of the VSV-ZEBOV candidate vaccine, manufactured by the Public Health Agency of Canada and developed by Merck, show that it "triggers the production of antibodies capable of neutralising the Ebola virus," the Geneva University Hospitals (HUG) said in a statement.



Too much iced tea caused Arkansas man's kidney problems
1 Apr 2015 at 2:26pm

NEW YORK (AP) ? Doctors traced an Arkansas man's kidney failure to an unusual cause ? his habit of drinking a gallon of iced tea each day.



The Importance of Community
1 Apr 2015 at 2:25pm

Throughout high school, college and after college, many of us are on a mission to have the highest number of friends possible. For some reason, we think it's quantity over quality. We're certain that we'll be cooler, happier and more popular based on a higher number - especially when social media comes into play. 'How many Facebook friends do...



DNA blood test is accurate for detecting Down syndrome
1 Apr 2015 at 2:20pm

A blood test for pregnant mothers that detects an unborn child's DNA is better than standard tests at detecting Down syndrome, and returns fewer false positives, US researchers said Wednesday. The cell-free DNA blood test, which finds small amounts of floating DNA from the fetus in the mother's blood sample, can be given to a woman when she is between 10 and 14 weeks pregnant. Researchers studied nearly 16,000 women, and found that the cell-free DNA blood test correctly identified all 38 fetuses with Down syndrome in the group, said the study in the New England Journal of Medicine.



10 Ebola cases found during Sierra Leone's shutdown
1 Apr 2015 at 12:20pm

FREETOWN, Sierra Leone (AP) ? Sierra Leone found 10 new Ebola cases during a three-day countrywide shutdown, an official said Wednesday, declaring that the West African country is now at the "tail end" of the epidemic.



10 Ways to Help Your Kid Get a Good Night's Sleep
1 Apr 2015 at 11:32am

By Erin Wilkey Oh, Common Sense Media editorParents know firsthand the impact a poor night's sleep has on kids. Lack of sleep can contribute to crankiness, problems with attention and learning, behavioral issues and even health problems such as obesity. Though the reasons for poor sleep vary, many parents worry that media and technology...



"New wave" of GMOs: pink pineapples, purple tomatoes
1 Apr 2015 at 11:11am

WASHINGTON (AP) ? With recent government approval of potatoes that don't bruise and apples that don't brown, a new generation of genetically modified foods is headed to grocery shelves.



LGBTQ Health Disparities Have Been Eliminated
1 Apr 2015 at 9:11am

I've worked in the field of LGBTQ health my whole adult life. Frankly, considering the depth of our disparities, I felt that I would have job security forever. After a careful analysis of the latest federal LGBTQ surveillance data, I'm extremely pleased to announce that the unthinkable has indeed occurred: LGBTQ health disparities have been...


Spring Cleaning for the Soul
1 Apr 2015 at 9:09am

We all know that this winter has been pretty rough with the seemingly endless blizzards, ice storms and sub-zero weather. But March marks the beginning of spring -- the season of change. Mother Nature runs her course, thawing life out of the winter cold and breathing new life into spring. People seem to reflect that same change this time of...


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC